Lanlan Si

405 total citations
21 papers, 306 citations indexed

About

Lanlan Si is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Lanlan Si has authored 21 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 19 papers in Hepatology and 3 papers in Infectious Diseases. Recurrent topics in Lanlan Si's work include Hepatitis B Virus Studies (20 papers), Hepatitis C virus research (19 papers) and Liver Disease Diagnosis and Treatment (13 papers). Lanlan Si is often cited by papers focused on Hepatitis B Virus Studies (20 papers), Hepatitis C virus research (19 papers) and Liver Disease Diagnosis and Treatment (13 papers). Lanlan Si collaborates with scholars based in China, Germany and France. Lanlan Si's co-authors include Dongping Xu, Zhihui Xu, Rongjuan Chen, Yan Liu, Xiaodong Li, Yan Liu, Jianhong Chen, Hao Liao, Kai Zhang and Le Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and World Journal of Gastroenterology.

In The Last Decade

Lanlan Si

21 papers receiving 303 citations

Peers

Lanlan Si

EPIDE

HEPAT

PHARM

Senem Ceren Karataylı Türkiye

Nora Goldmann Germany

Alexis José-Ábrego Mexico

Noorann Sheikh United Kingdom

Kazane Nishioka Japan

Yoko Tamada Japan

Alina Jucov Moldova

Zahary Krastev Bulgaria

Soree Park South Korea

Lubna Ghanem Denmark

Senem Ceren Karataylı Türkiye

Lanlan Si

446 ×1.6

EPIDE

438 ×1.7

HEPAT

46 ×0.9

36 ×1.4

3 ×0.2

PHARM

Citations per year, relative to Lanlan Si Lanlan Si (= 1×) peers Senem Ceren Karataylı

Countries citing papers authored by Lanlan Si

Since Specialization

Citations

This map shows the geographic impact of Lanlan Si's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanlan Si with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanlan Si more than expected).

Fields of papers citing papers by Lanlan Si

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lanlan Si. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanlan Si. The network helps show where Lanlan Si may publish in the future.

Co-authorship network of co-authors of Lanlan Si

This figure shows the co-authorship network connecting the top 25 collaborators of Lanlan Si. A scholar is included among the top collaborators of Lanlan Si based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lanlan Si. Lanlan Si is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Yan, Lanlan Si, Yuanhua Li, et al.. (2024). Inhibition of hepatitis B virus via selective apoptosis modulation by Chinese patent medicine Liuweiwuling Tablet. World Journal of Gastroenterology. 30(13). 1911–1925. 3 indexed citations

Shi, Qiwen, Pengfei Zhang, Qingtao Hu, et al.. (2024). Role of TOMM34 on NF-κB activation-related hyperinflammation in severely ill patients with COVID-19 and influenza. EBioMedicine. 108. 105343–105343. 1 indexed citations

Yang, Yan, Zhaofang Bai, Lanlan Si, et al.. (2023). The role of Traditional Chinese medicine in anti-HBV: background, progress, and challenges. Chinese Medicine. 18(1). 159–159. 9 indexed citations

Liao, Hao, He Zhang, Xiaoyong Li, et al.. (2023). Nucleos(t)ide analogues altered quasispecies composition of hepatitis B virus (HBV)‐resistant mutations in serum HBV DNA and serum HBV RNA. Journal of Medical Virology. 95(3). 2 indexed citations

Liao, Hao, Wei Zheng, Jun Zou, et al.. (2022). Characteristics of HBV Novel Serum Markers across Distinct Phases in Treatment-Naïve Chronic HBV-Infected Patients. Disease Markers. 2022. 1–13. 7 indexed citations

Liu, Yan, Rongjuan Chen, Wenhui Liu, et al.. (2021). Investigation of multidrug-resistance mutations of hepatitis B virus (HBV) in a large cohort of chronic HBV-infected patients with treatment of nucleoside/nucleotide analogs. Antiviral Research. 189. 105058–105058. 8 indexed citations

Si, Lanlan, Yan Yang, Yuanhua Li, et al.. (2021). Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Suppressed HBV Replication in Mouse Model. Frontiers in Pharmacology. 12. 756975–756975. 19 indexed citations

Chen, Rongjuan, Yan Liu, Lanlan Si, et al.. (2020). Hepatitis B virus mutation pattern rtA181S+T184I+M204I may contribute to multidrug resistance in clinical practice: Analysis of a large cohort of Chinese patients. Antiviral Research. 180. 104852–104852. 7 indexed citations

Wang, Jun, Yan Liu, Hao Liao, et al.. (2020). The sK122R mutation of hepatitis B virus (HBV) is associated with occult HBV infection: Analysis of a large cohort of Chinese patients. Journal of Clinical Virology. 130. 104564–104564. 13 indexed citations

10.

Huang, Bixia, Yan Liu, Lanlan Si, et al.. (2020). Investigation of immune escape-associated mutations of hepatitis B virus in patients harboring hepatitis B virus drug-resistance mutations. World Journal of Gastroenterology. 26(35). 5314–5327. 3 indexed citations

11.

Liu, Yan, Yi Zhou, Xiaodong Li, et al.. (2019). Hepatitis B virus mutation pattern rtL180M+A181C+M204V may contribute to entecavir resistance in clinical practice. Emerging Microbes & Infections. 8(1). 354–365. 19 indexed citations

12.

Liu, Yan, Weiming Yao, Lanlan Si, et al.. (2018). Chinese herbal extract Su-duxing had potent inhibitory effects on both wild-type and entecavir-resistant hepatitis B virus (HBV) in vitro and effectively suppressed HBV replication in mouse model. Antiviral Research. 155. 39–47. 28 indexed citations

13.

Zhang, Kai, Yan Liu, Rongjuan Chen, et al.. (2017). Antigenicity reduction contributes mostly to poor detectability of HBsAg by hepatitis B virus (HBV) S‐gene mutants isolated from individuals with occult HBV infection. Journal of Medical Virology. 90(2). 263–270. 20 indexed citations

14.

Liao, Hao, Yan Liu, Jianhong Chen, et al.. (2017). Characterization of hepatitis B virus (HBV) preS/S gene mutations in blood donors with occult HBV infection in the Baoji area of North China. Transfusion. 57(3pt2). 857–866. 25 indexed citations

15.

Qiao, Yan, Shanshan Lu, Zhihui Xu, et al.. (2017). Additional N-glycosylation mutation in the major hydrophilic region of hepatitis B virus S gene is a risk indicator for hepatocellular carcinoma occurrence in patients with coexistence of HBsAg/anti-HBs. Oncotarget. 8(37). 61719–61730. 15 indexed citations

16.

Chen, Jianhong, Yan Liu, Jun Zhao, et al.. (2016). Characterization of Novel Hepatitis B Virus PreS/S-Gene Mutations in a Patient with Occult Hepatitis B Virus Infection. PLoS ONE. 11(5). e0155654–e0155654. 40 indexed citations

17.

Wang, Yan, Yan Liu, Zhihui Xu, et al.. (2012). Phenotypic characteristics of a novel mutation rtM204Q in the reverse-transcriptase domain of hepatitis B virus isolated from a chronic hepatitis B patient receiving lamivudine treatment. Jiefangjun yixue zazhi. 37(6). 446–450. 1 indexed citations

18.

Ji, Dong, Yan Liu, Le Li, et al.. (2012). The rtL229 substitutions in the reverse transcriptase region of hepatitis B virus (HBV) polymerase are potentially associated with lamivudine resistance as a compensatory mutation. Journal of Clinical Virology. 54(1). 66–72. 31 indexed citations

19.

Xu, Zhihui, Yan Liu, Teng Xu, et al.. (2010). Acute hepatitis B infection associated with drug-resistant hepatitis B virus. Journal of Clinical Virology. 48(4). 270–274. 41 indexed citations

20.

Ji, Dong, Yan Liu, Lanlan Si, et al.. (2010). Variable influence of mutational patterns in reverse-transcriptase domain on replication capacity of hepatitis B virus isolates from antiviral-experienced patients. Clinica Chimica Acta. 412(3-4). 305–313. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact